LARIAM Side Effects

6974608-3 | Abnormal Dreams, Anxiety, Delusion, Insomnia, Paranoia, Suicidal Ideation, Tachycardia
on Sep 09, 2010 Female patient from UNITED STATES , 32 years of age, weighting 240.0 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal dreams, anxiety (What is anxiety?), delusion, insomnia, paranoia, suicidal ideation, tachycardia. Lariam dosage: . Patient was hospitalized.

6723578-1 | Pancytopenia
Patient was taking Lariam (View Usage). Patient had the following side effects: pancytopenia on Mar 05, 2010 from GERMANY Additional patient health information: Female patient , 74 years of age, weighting 165.3 lb, was diagnosed with leukoencephalopathy, hashimoto's encephalopathy, reflux oesophagitis, coronary artery disease (What is coronary artery disease?), diabetes mellitus and. Lariam dosage: . During the same period patient was treated with TORSEMIDE (View Torsemide Review and Torsemide Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), PANTOZOL (Form: Gastro-resistant Tablet) (View Pantozol Review and Pantozol Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ISCOVER (Form:film Coated Tablet) (View Iscover Review and Iscover Label ), ACTRAPID (Form:injection) (View Actrapid Review and Actrapid Label ), PREDNISOLON (View Prednisolon Review and Prednisolon Label ), DIGITOXIN (View Digitoxin Review and Digitoxin Label ). Patient was hospitalized.

6686484-7 | Angioedema
Adverse event was reported on Apr 06, 2010 by a Female patient taking Lariam (View Usage) (Dosage: ) was diagnosed with malaria prophylaxis and. Location: SWEDEN , 18 years of age, After Lariam was administered, patient had the following side effects: angioedema. During the same period patient was treated with DIMOR (View Dimor Review and Dimor Label ).

6646722-3 | Erectile Dysfunction, Overdose, Pancreatitis
on Mar 09, 2010 Male patient from GERMANY , weighting 172.0 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: erectile dysfunction (What is erectile dysfunction?), overdose, pancreatitis. Lariam dosage: .


6642420-0 | Abasia, Agitation, Alanine Aminotransferase Increased, Asthenia, Ataxia, Bundle Branch Block, Confusional State, Deafness, Dizziness
on Mar 11, 2010 Female patient from UNITED STATES , 82 years of age, was diagnosed with migraine (What is migraine?) and was treated with Lariam (View Usage). Patient had the following side effects: abasia, agitation, alanine aminotransferase increased, asthenia, ataxia (What is ataxia?), bundle branch block, confusional state, deafness, dizziness (What is dizziness?). Lariam dosage: Total Dose Of 15250 Mg. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), APRESOLINE (View Apresoline Review and Apresoline Label ), DESYREL (View Desyrel Review and Desyrel Label ), ULTRAM (View Ultram Review and Ultram Label ), PROPOXYPHENE HCL (View Propoxyphene Hcl Review and Propoxyphene Hcl Label ).

6624728-8 | Bradycardia, Disorientation, Impaired Driving Ability, Nausea, Palpitations, Sleep Disorder, Supraventricular Tachycardia
Patient was taking Lariam (View Usage). After Lariam was administered, patient had the following side effects: bradycardia, disorientation, impaired driving ability, nausea (What is nausea?), palpitations, sleep disorder (What is sleep disorder?), supraventricular tachycardia on Mar 03, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 48 years of age, was diagnosed with malaria prophylaxis and. Lariam dosage: Action Taken: Withdrawn.. Patient was hospitalized.

6612109-2 | Insomnia, Psychotic Disorder
Adverse event was reported on Mar 02, 2010 by a Male patient taking Lariam (View Usage) (Dosage: Weekly Po) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , 22 years of age, weighting 235.0 lb, Patient experienced the following unwanted or unexpected effects: insomnia, psychotic disorder (What is psychotic disorder?).

6611852-9 | Pancytopenia
on Feb 25, 2010 Female patient from GERMANY , 74 years of age, weighting 165.3 lb, was diagnosed with leukoencephalopathy, hashimoto's encephalopathy, reflux oesophagitis, coronary artery disease (What is coronary artery disease?), diabetes mellitus and was treated with Lariam (View Usage). Patient had the following side effects: pancytopenia. Lariam dosage: . During the same period patient was treated with TOREM (View Torem Review and Torem Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), PANTOZOL (Form: Gastro-resistant Tablet) (View Pantozol Review and Pantozol Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ISCOVER (Form:film Coated Tablet) (View Iscover Review and Iscover Label ), ACTRAPID (Form:injection) (View Actrapid Review and Actrapid Label ), PREDNISOLON (View Prednisolon Review and Prednisolon Label ), DIGITOXIN INJ (View Digitoxin Inj Review and Digitoxin Inj Label ). Patient was hospitalized.

6590405-5 | Psychotic Disorder
on Feb 11, 2010 Female patient from SWEDEN , 20 years of age, was diagnosed with prophylaxis and was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: psychotic disorder (What is psychotic disorder?). Lariam dosage: Reported As Lariam Tabl. Dose Reported As 250 Mgw. Patient was hospitalized.

6585163-4 | Anxiety, Mental Disorder
Patient was taking Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), mental disorder on Feb 04, 2010 from NETHERLANDS Additional patient health information: Male patient , weighting 220.5 lb, was diagnosed with malaria prophylaxis and. Lariam dosage: .

6518124-1 | Depression, Sleep Disorder, Suicidal Ideation
Adverse event was reported on Dec 23, 2009 by a Male patient taking Lariam (View Usage) (Dosage: 1/week Po) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , 29 years of age, weighting 205.0 lb, Patient had the following side effects: depression (What is depression?), sleep disorder (What is sleep disorder?), suicidal ideation.

6503113-3 | Confusional State, Hallucination, Immune Reconstitution Syndrome
on Dec 08, 2009 Male patient from SWITZERLAND , 64 years of age, weighting 147.7 lb, was diagnosed with progressive multifocal leukoencephalopathy, epilepsy (What is epilepsy?), prophylaxis and was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: confusional state, hallucination, immune reconstitution syndrome. Lariam dosage: . During the same period patient was treated with REMERON (View Remeron Review and Remeron Label ), KALETRA (View Kaletra Review and Kaletra Label ), TRUVADA (View Truvada Review and Truvada Label ), KEPPRA (View Keppra Review and Keppra Label ), BENERVA (View Benerva Review and Benerva Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6458750-1 | Narcolepsy, Somnolence
on Nov 16, 2009 Female patient from UNITED KINGDOM , 16 years of age, was diagnosed with malaria prophylaxis, foreign travel and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: narcolepsy, somnolence. Lariam dosage: . During the same period patient was treated with VACCINES NOS (View Vaccines Nos Review and Vaccines Nos Label ).

6402365-8 | Post Concussion Syndrome, Suicidal Ideation
Patient was taking Lariam (View Usage). Patient had the following side effects: post concussion syndrome, suicidal ideation on Oct 06, 2009 from UNITED STATES Additional patient health information: Male patient , 36 years of age, was diagnosed with malaria prophylaxis and. Lariam dosage: . During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ).

6386657-7 | Constipation, Rash
Adverse event was reported on Oct 01, 2009 by a Female patient taking Lariam (View Usage) (Dosage: ) was diagnosed with malaria prophylaxis and. Location: GERMANY , 22 years of age, After Lariam was administered, patient had the following side effects: constipation (What is constipation?), rash (What is rash?). Patient was hospitalized.

6341111-3 | Constipation
on Aug 28, 2009 Female patient from GERMANY , 22 years of age, was diagnosed with prophylaxis and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?). Lariam dosage: . Patient was hospitalized.

6250672-4 | Aphasia, Cognitive Disorder, Delusion, Dissociation, Dizziness, Fatigue, Headache, Hyperhidrosis, Skin Disorder
on Jun 18, 2009 Male patient from GERMANY , weighting 169.8 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient had the following side effects: aphasia (What is aphasia?), cognitive disorder, delusion, dissociation, dizziness (What is dizziness?), fatigue, headache (What is headache?), hyperhidrosis, skin disorder. Lariam dosage: . Patient was hospitalized.

6219441-5 | Mania
Patient was taking Lariam (View Usage). After Lariam was administered, patient had the following side effects: mania on Jan 26, 2009 from UNITED STATES Additional patient health information: Female patient , 18 years of age, . Lariam dosage: . Patient was hospitalized.

6219439-7 | Abdominal Pain Upper, Completed Suicide, Psychogenic Pain Disorder
Adverse event was reported on Oct 13, 2008 by a Male patient taking Lariam (View Usage) (Dosage: ) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , 25 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, completed suicide, psychogenic pain disorder.

6219439-7 | Abdominal Pain Upper, Completed Suicide, Psychogenic Pain Disorder
on Oct 13, 2008 Male patient from UNITED STATES , 25 years of age, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient had the following side effects: abdominal pain upper, completed suicide, psychogenic pain disorder. Lariam dosage: .

6182450-9 | Anxiety, Brain Injury, Convulsion, Fear, Memory Impairment
on Apr 29, 2009 Female patient from UNITED KINGDOM , 38 years of age, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: anxiety (What is anxiety?), brain injury, convulsion, fear, memory impairment. Lariam dosage: .

6171274-4 | Abnormal Dreams, Depression, Dyspnoea, Hypophagia, Insomnia, Panic Attack, Psychomotor Retardation, Weight Decreased
Patient was taking Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal dreams, depression (What is depression?), dyspnoea, hypophagia, insomnia, panic attack, psychomotor retardation, weight decreased on Apr 28, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 170.0 lb, was diagnosed with malaria prophylaxis and. Lariam dosage: 250 Mg Weekly Po, 3-4 Doses. During the same period patient was treated with AMBIEN (View Ambien Review and Ambien Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), PERIACTIN (View Periactin Review and Periactin Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), CLARITIN (View Claritin Review and Claritin Label ). Patient was hospitalized.

6157667-X | Anhedonia, Anxiety, Asthenia, Balance Disorder, Brain Injury, Burning Sensation, Confusional State, Disorientation, Dizziness
Adverse event was reported on Apr 14, 2009 by a Male patient taking Lariam (View Usage) (Dosage: 250 Mg Weekly Po) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , 55 years of age, weighting 210.0 lb, Patient had the following side effects: anhedonia, anxiety (What is anxiety?), asthenia, balance disorder, brain injury, burning sensation, confusional state, disorientation, dizziness (What is dizziness?).

6155267-9 | Anxiety, Diarrhoea, Dizziness, Pyrexia, Skin Burning Sensation, Tinnitus, Tremor
on Apr 10, 2009 Female patient from UNITED STATES , 54 years of age, weighting 119.0 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: anxiety (What is anxiety?), diarrhoea, dizziness (What is dizziness?), pyrexia, skin burning sensation, tinnitus (What is tinnitus?), tremor. Lariam dosage: 250 Mg Once A Week Po.

6154073-9 | Blood Pressure Increased, Dehydration, Gastritis, Vestibular Neuronitis
on Mar 31, 2009 Female patient from FRANCE , weighting 121.3 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, dehydration, gastritis, vestibular neuronitis. Lariam dosage: . Patient was hospitalized.

6145878-9 | Abnormal Dreams, Agitation, Anxiety, Asthenia, Cardiovascular Disorder, Coordination Abnormal, Depression, Disturbance In Attention, Dyspepsia
Patient was taking Lariam (View Usage). Patient had the following side effects: abnormal dreams, agitation, anxiety (What is anxiety?), asthenia, cardiovascular disorder, coordination abnormal, depression (What is depression?), disturbance in attention, dyspepsia on Apr 01, 2009 from GERMANY Additional patient health information: Female patient , weighting 149.9 lb, was diagnosed with malaria prophylaxis and. Lariam dosage: Dosage Regimen Reported As Four Tabs In Total. Weekly Dosage.. Patient was hospitalized.

6142028-X | Activities Of Daily Living Impaired, Anxiety, Asthenia, Insomnia, Nightmare, Palpitations
Adverse event was reported on Mar 31, 2009 by a Female patient taking Lariam (View Usage) (Dosage: 11 Weekly Po) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , 72 years of age, weighting 118.0 lb, After Lariam was administered, patient had the following side effects: activities of daily living impaired, anxiety (What is anxiety?), asthenia, insomnia, nightmare, palpitations.

6134700-2 | Blood Pressure Increased, Dehydration, Gastritis, Vestibular Neuronitis
on Mar 16, 2009 Female patient from FRANCE , 72 years of age, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, dehydration, gastritis, vestibular neuronitis. Lariam dosage: . Patient was hospitalized.

6124240-9 | Anxiety, Brain Injury, Convulsion, Fear, Memory Impairment
on Mar 08, 2009 Female patient from UNITED KINGDOM , 38 years of age, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient had the following side effects: anxiety (What is anxiety?), brain injury, convulsion, fear, memory impairment. Lariam dosage: .

6115524-9 | Cognitive Disorder, Confusional State, Memory Impairment, Speech Disorder, Unresponsive To Stimuli
Patient was taking Lariam (View Usage). After Lariam was administered, patient had the following side effects: cognitive disorder, confusional state, memory impairment, speech disorder, unresponsive to stimuli on Mar 03, 2009 from GERMANY Additional patient health information: Male patient , 32 years of age, . Lariam dosage: .

6097639-7 | Fear, Hypoaesthesia, Insomnia, Palpitations, Panic Attack, Paraesthesia, Tremor
Adverse event was reported on Feb 25, 2009 by a Female patient taking Lariam (View Usage) (Dosage: 1 Weekly Po) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , weighting 120.0 lb, Patient experienced the following unwanted or unexpected effects: fear, hypoaesthesia, insomnia, palpitations, panic attack, paraesthesia, tremor.

6061512-0 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Bradycardia, Gamma-glutamyltransferase Increased, Nausea, Vertigo
on Jan 19, 2009 Female patient from FRANCE , 74 years of age, weighting 121.3 lb, was treated with Lariam (View Usage). Patient had the following side effects: abdominal pain upper, alanine aminotransferase increased, bradycardia, gamma-glutamyltransferase increased, nausea (What is nausea?), vertigo. Lariam dosage: . Patient was hospitalized.

6059290-4 | Renal Failure Acute, Rhabdomyolysis, Syncope
on Jan 22, 2009 Male patient from UNITED KINGDOM , 23 years of age, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: renal failure acute, rhabdomyolysis, syncope. Lariam dosage: . Patient was hospitalized.

6043585-4 | Aggression, Psychotic Disorder, Rash, Tinnitus, Vision Blurred
Patient was taking Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, psychotic disorder (What is psychotic disorder?), rash (What is rash?), tinnitus (What is tinnitus?), vision blurred on Jan 15, 2009 from UNITED STATES Additional patient health information: Female patient , 14 years of age, weighting 140.0 lb, was diagnosed with malaria prophylaxis and. Lariam dosage: 250 Mg Once A Week Po. Patient was hospitalized.

6011707-7 | Disease Progression
Adverse event was reported on Jan 16, 1991 by a Male patient taking Lariam (View Usage) (Dosage: ) . Location: CANADA , 35 years of age, Patient had the following side effects: disease progression. During the same period patient was treated with SPIRAMYCIN (View Spiramycin Review and Spiramycin Label ), DICLAZURIL (View Diclazuril Review and Diclazuril Label ), SOMATOSTATIN (View Somatostatin Review and Somatostatin Label ). Patient was hospitalized and became disabled.

6011699-0 | Cerebral Malaria, Pneumonia Aspiration, Pulmonary Oedema, Shock
on Jun 26, 1989 Male patient from SWITZERLAND , 70 years of age, was diagnosed with malaria (What is malaria?) and was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: cerebral malaria, pneumonia aspiration, pulmonary oedema, shock. Lariam dosage: . During the same period patient was treated with QUININE (View Quinine Review and Quinine Label ).

5999479-3 | Convulsion
on Dec 11, 2008 Female patient from UNITED STATES , 48 years of age, weighting 160.0 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Lariam dosage: Weekly Mouth. During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ).

5976068-8 | Choking Sensation, Dehydration, Depression, Fall, Panic Attack, Paranoia, Psychotic Disorder, Swollen Tongue
Patient was taking Lariam (View Usage). Patient had the following side effects: choking sensation, dehydration, depression (What is depression?), fall (What is fall?), panic attack, paranoia, psychotic disorder (What is psychotic disorder?), swollen tongue on Nov 21, 2008 from UNITED STATES Additional patient health information: Female patient , 71 years of age, was diagnosed with prophylaxis and. Lariam dosage: . During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

5976051-2 | Agitation, Arthralgia, Chest Pain, Confusional State, Constipation, Conversion Disorder, Deafness, Depression, Dysphagia
Adverse event was reported on Nov 20, 2008 by a Male patient taking Lariam (View Usage) (Dosage: ) was diagnosed with malaria prophylaxis, blood pressure (What is blood pressure?), arthritis (What is arthritis?), hypertension and. Location: UNITED STATES , weighting 177.9 lb, After Lariam was administered, patient had the following side effects: agitation, arthralgia, chest pain (What is chest pain?), confusional state, constipation (What is constipation?), conversion disorder, deafness, depression (What is depression?), dysphagia. During the same period patient was treated with NAPROXEN (View Naproxen Review and Naproxen Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized and became disabled.

5972754-4 | Claustrophobia, Feeling Abnormal, Panic Attack
on Nov 26, 2008 Female patient from UNITED STATES , 44 years of age, weighting 120.0 lb, was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: claustrophobia, feeling abnormal, panic attack. Lariam dosage: .

5955004-4 | Anxiety, Chest Pain, Diarrhoea, Dyspepsia, Dyspnoea, Insomnia, Myalgia, Pulmonary Embolism, Vomiting
on Nov 13, 2008 Male patient from UNITED STATES , 22 years of age, weighting 165.0 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient had the following side effects: anxiety (What is anxiety?), chest pain (What is chest pain?), diarrhoea, dyspepsia, dyspnoea, insomnia, myalgia, pulmonary embolism (What is pulmonary embolism?), vomiting. Lariam dosage: 250mg Weekly Po. Patient was hospitalized.

5951184-5 | Anxiety, Balance Disorder, Bronchitis, Hallucination, Auditory, Metabolic Disorder, Overdose, Panic Attack, Pneumonitis, Vestibular Disorder
Patient was taking Lariam (View Usage). After Lariam was administered, patient had the following side effects: anxiety (What is anxiety?), balance disorder, bronchitis (What is bronchitis?), hallucination, auditory, metabolic disorder (What is metabolic disorder?), overdose, panic attack, pneumonitis, vestibular disorder on Nov 12, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 170.0 lb, . Lariam dosage: 250mg Weekly Po.

5920895-X | Acute Respiratory Failure, Pulmonary Toxicity, Shock
Adverse event was reported on Oct 06, 2008 by a Male patient taking Lariam (View Usage) (Dosage: ) . Location: GERMANY , 59 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: acute respiratory failure, pulmonary toxicity, shock. Patient was hospitalized and became disabled.

5904319-4 | Abnormal Dreams, Activities Of Daily Living Impaired, Anxiety, Asthenia, Balance Disorder, Depression, Discomfort, Dyskinesia, Eating Disorder
on Sep 30, 2008 Female patient from UNITED STATES , 22 years of age, weighting 145.0 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient had the following side effects: abnormal dreams, activities of daily living impaired, anxiety (What is anxiety?), asthenia, balance disorder, depression (What is depression?), discomfort, dyskinesia, eating disorder (What is eating disorder?). Lariam dosage: 250mg 1/week Po. Patient was hospitalized.

5891587-0 | Euphoric Mood, Hallucination, Nausea, Persecutory Delusion, Pyrexia
on Sep 09, 2008 Female patient from FRANCE , 18 years of age, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: euphoric mood, hallucination, nausea (What is nausea?), persecutory delusion, pyrexia. Lariam dosage: .

5868533-9 | Amnesia, Physical Assault, Post-traumatic Stress Disorder, Sexual Abuse, Theft
Patient was taking Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, physical assault, post-traumatic stress disorder (What is post-traumatic stress disorder?), sexual abuse, theft on Aug 23, 2008 from UNITED STATES Additional patient health information: Male patient , 24 years of age, . Lariam dosage: .

5867094-8 | Anxiety, Arthralgia, Confusional State, Depression, Dizziness, Ear Pain, Fatigue, Hallucination, Headache
Adverse event was reported on Aug 29, 2008 by a Male patient taking Lariam (View Usage) (Dosage: 1 Pill 1 Per Week) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , 19 years of age, weighting 200.0 lb, Patient had the following side effects: anxiety (What is anxiety?), arthralgia, confusional state, depression (What is depression?), dizziness (What is dizziness?), ear pain, fatigue, hallucination, headache (What is headache?).

5854000-5 | Abortion Spontaneous
on Aug 19, 2008 Female patient from GERMANY , weighting 149.9 lb, was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: abortion spontaneous. Lariam dosage: .

5853999-0 | Amnesia, Hypersensitivity, Tachycardia
on Aug 12, 2008 Female patient from GERMANY , 40 years of age, was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, hypersensitivity, tachycardia. Lariam dosage: .

5849623-3 | Crying, Dyspnoea
Patient was taking Lariam (View Usage). Patient had the following side effects: crying, dyspnoea on Aug 08, 2008 from UNITED KINGDOM Additional patient health information: Female patient , weighting 17.64 lb, was diagnosed with malaria (What is malaria?) and. Lariam dosage: Reported As Mefloquine Given 'crushed In Water'.